黑料网大事记

Dr Didu Kariyawasam

Dr Didu Kariyawasam

Lecturer
BA, MA(Cantab), MRCPCH, RACP, PhD
Medicine & Health
School of Clinical Medicine

Dr Didu (Sandi) Kariyawasamn is a paediatric neurologist, and post doctoral researcher at 黑料网大事记 Sydney. She听completed her Masters at the University of Cambridge, UK, subsequently graduating from University College London in 2007. She embarked on her training in Paediatric Neurology at John Radcliffe Hospital, Oxford, UK, gaining specialist expertise in the management of complex epilepsy (Great Ormond Street Hospital, London), movement disorders (Evelina Children鈥檚 Hospital London) and neuroinflammation (John Radcliffe Hospital, Oxford). In 2022, Sandi successfully completed a PhD in the investigation of pathways to optimise diagnosis and care for children with Neurogenetic disease.

Sandi currently practices clinically at Sydney Children鈥檚 Hospital (Randwick), and as an early career researcher, holds the title of associate lecturer at the University of New South Wales. She recently completed her PhD (2022),听evaluating the novel diagnostic and management pathways in paediatric neuromuscular disease (NMD).听

Sandi is active in the field of clinical trials and is part of the clinical research team providing access to new genetic therapies in the field of childhood onset neurological disease. Her work has been translational in the domain of paediatric neuromuscular disease where she strives to improve health and psychosocial outcomes for affected children and their families.听

Sandi's goal is to provide optimal care and informed choice for families, based on best current evidence, taking into account the values and beliefs of the individual. The ethos that underpins her work is maintaining a child- and family-centred focus to improve the health and well-being of her patients.

Location
Bright Alliance, Randwick Clinical Campus, 黑料网大事记 Sydney
  • Journal articles | 2025
    Balaji L; Farrar MA; Yiu EM; Kariyawasam D, 2025, 'A state-of-the-art review of registries in spinal muscular atrophy: A valuable resource for clinical research', Journal of Neuromuscular Diseases, 12, pp. 312 - 329,
    Journal articles | 2025
    Balaji L; Kariyawasam D; Herbert K; Sampaio HA; Cairns A; McGill BC; Kelada L; Woolfenden S; Briggs N; Farrar MA, 2025, 'Neurodevelopmental screening in children with early-onset spinal muscular atrophy in the treatment era: A strengths-based cohort study', Brain Communications, 7,
    Journal articles | 2025
    Djafar J; Nevin S; Smith N; Ardern-Holmes S; Bhattacharya K; Dale R; Ellaway C; Grattan S; Johnson A; Kandula T; Kariyawasam DS; Lewis K; Meagher CE; Mohammad S; Farrar MA, 2025, ''Fighting every day': Exploring caregiver quality of life and perspectives on healthcare services for children with dementia - A cross-sectional, mixed-methods study', Archives of Disease in Childhood, 110, pp. 566 - 572,
    Journal articles | 2025
    Farrar MA; Mandarakas M; Briggs N; Cairns AG; Herbert K; Junek Z; Kandula T; Russell J; Sampaio H; Kariyawasam D, 2025, 'Gestational Age at Birth and Clinical Manifestations of Spinal Muscular Atrophy', Neurology, 105, pp. e213799,
    Journal articles | 2025
    Meagher CE; Kariyawasam DS; Concepcion KAE; Dale R; Hetherington K; Mohammad S; Palmer EE; Woolfenden S; Farrar MA, 2025, 'Codesign and evaluation of advanced therapeutic information resources for and with families of children with neurological conditions: A mixed methods cross-sectional study', Archives of Disease in Childhood, 110, pp. 308 - 315,
    Journal articles | 2025
    Woodcock IR; Kariyawasam DS; Kava MP; Yiu EM; Clark D; Adams J; Bischof M; Peacock A; Taylor C; Smith NJC, 2025, 'Cost-Effectiveness of Newborn Screening for Spinal Muscular Atrophy in Australian Hospitals', Neurology and Therapy, 14, pp. 1007 - 1022,
    Journal articles | 2024
    Balaji L; Forbes R; Cairns A; Sampaio H; Kornberg AJ; Sanders L; Lamont P; Liang C; Jones KJ; Nowak K; O'Gorman C; Woodcock I; Briggs N; Yiu EM; Farrar MA; Kariyawasam D, 2024, 'A contemporary analysis of the Australian clinical and genetic landscape of spinal muscular atrophy: a registry based study', Lancet Regional Health Western Pacific, 53, pp. 101237,
    Journal articles | 2024
    Farrar MA; Kariyawasam DS, 2024, 'Deciphering spinal muscular atrophy: the need for more research', Lancet Neurology, 23, pp. 134 - 136,
    Journal articles | 2024
    Ji C; Kariyawasam DS; Sampaio H; Lorentzos M; Jones KJ; Farrar MA, 2024, 'Newborn screening for Duchenne muscular dystrophy: the perspectives of stakeholders', Lancet Regional Health Western Pacific, 45,
    Journal articles | 2024
    Kariyawasam DS; Scarfe J; Meagher C; Farrar MA; Bhattacharya K; Carter SM; Newson AJ; Otlowski M; Watson J; Millis N; Norris S, 2024, '鈥業ntegrating Ethics and Equity with Economics and Effectiveness for newborn screening in the genomic age: A qualitative study protocol of stakeholder perspectives', Plos One, 19, pp. 1 - 13,
    Journal articles | 2024
    Nguyen CQ; Kariyawasam DST; Ngai TSJ; Nguyen J; Alba-Concepcion K; Grattan SE; Palmer EE; Hetherington K; Wakefield CE; Dale RC; Woolfenden S; Mohammad S; Farrar MA, 2024, '鈥楬igh hopes for treatment鈥: Australian stakeholder perspectives of the clinical translation of advanced neurotherapeutics for rare neurological diseases', Health Expectations, 27,
    Journal articles | 2023
    Balaji L; Farrar MA; D鈥橲ilva AM; Kariyawasam DS; D'Silva A, 2023, 'Decision-making and challenges within the evolving treatment algorithm in spinal muscular atrophy: a clinical perspective', Expert Review of Neurotherapeutics, 23, pp. 571 - 586,
    Journal articles | 2023
    Davidson JE; Russell JS; Martinez NN; Mowat DR; Jones KJ; Kirk EP; Kariyawasam D; Farrar M; D鈥橲ilva A, 2023, 'The Carrier Frequency of Two SMN1 Genes in Parents of Symptomatic Children with SMA and the Significance of SMN1 Exon 8 in Carriers', Genes, 14,
    Journal articles | 2023
    Djafar JV; Smith NJ; Johnson AM; Bhattacharya K; Ardern-Holmes SL; Ellaway C; Dale RC; D'Silva AM; Kariyawasam DS; Grattan S; Kandula T; Lewis K; Mohammed SS; Farrar MA, 2023, 'Characterizing Common Phenotypes Across the Childhood Dementia Disorders: A Cross-sectional Study From Two Australian Centers', Pediatric Neurology, 149, pp. 75 - 83,
    Journal articles | 2023
    D鈥橲ilva AM; Kariyawasam D; Venkat P; Mayoh C; Farrar MA, 2023, 'Identification of Novel CSF-Derived miRNAs in Treated Paediatric Onset Spinal Muscular Atrophy: An Exploratory Study', Pharmaceutics, 15,
    Journal articles | 2023
    Farrar MA; Calotes-Castillo L; De Silva R; Barclay P; Attwood L; Cini J; Ferrie M; Kariyawasam DS, 2023, 'Gene therapy-based strategies for spinal muscular atrophy鈥攁n Asia-Pacific perspective', Molecular and Cellular Pediatrics, 10,
    Journal articles | 2023
    Farrar MA; Kariyawasam D; Grattan S; Bayley K; Davis M; Holland S; Waddel LB; Jones K; Lorentzos M; Ravine A; Wotton T; Wiley V, 2023, 'Newborn Screening for the Diagnosis and Treatment of Duchenne Muscular Dystrophy', Journal of Neuromuscular Diseases, 10, pp. 15 - 28,
    Journal articles | 2023
    Farrar MA; Kiernan MC; Kariyawasam DS, 2023, 'Presymptomatic spinal muscular atrophy: a cautionary approach to the proposed new terminology', Brain, 146, pp. E65 - E66,
    Journal articles | 2023
    Ji C; Farrar MA; Norris S; Bhattacharya K; Bennetts B; Newson AJ; Healy L; Millis N; Kariyawasam DS, 2023, 'The Australian landscape of newborn screening in the genomics era', Rare Disease and Orphan Drugs Journal, 2,
    Journal articles | 2023
    Kariyawasam DS; D'Silva AM; Sampaio H; Briggs N; Herbert K; Wiley V; Farrar MA, 2023, 'Newborn screening for spinal muscular atrophy in Australia: a non-randomised cohort study', Lancet Child and Adolescent Health, 7, pp. 159 - 170,
    Journal articles | 2023
    Le Marne FA; Briggs N; Frith K; Kariyawasam D; McCarthy HJ; Nunn K; Rao A; Sachdev R; Sarkozy V; Teng A; Trethewie S; Williams GD; Bye AME, 2023, 'Understanding the ongoing learning needs of Australian paediatricians: Evaluation of a pilot paediatric video teaching programme', Journal of Paediatrics and Child Health, 59, pp. 307 - 318,
    Journal articles | 2022
    D'Silva AM; Holland S; Kariyawasam D; Herbert K; Barclay P; Cairns A; MacLennan SC; Ryan MM; Sampaio H; Smith N; Woodcock IR; Yiu EM; Alexander IE; Farrar MA, 2022, 'Onasemnogene abeparvovec in spinal muscular atrophy: an Australian experience of safety and efficacy', Annals of Clinical and Translational Neurology, 9, pp. 339 - 350,
    Journal articles | 2022
    D'Silva AM; Kariyawasam DST; Best S; Wiley V; Farrar MA; Ravine A; Mowat D; Sampaio H; Alexander IE; Russell J; Jones K; Junek Z, 2022, 'Integrating newborn screening for spinal muscular atrophy into health care systems: an Australian pilot programme', Developmental Medicine and Child Neurology, 64, pp. 625 - 632,
    Journal articles | 2022
    Kariyawasam D; D'Silva A; Farrar M; Shin-Yi Lin C, 2022, 'WE-149. Axonal excitability changes in children with spinal muscular atrophy treated with nusinersen', Clinical Neurophysiology, 141, pp. S73 - S74,
    Journal articles | 2022
    Kariyawasam D; D鈥橲ilva A; Mowat D; Russell J; Sampaio H; Jones K; Taylor P; Farrar M, 2022, 'Incidence of Duchenne muscular dystrophy in the modern era; an Australian study', European Journal of Human Genetics, 30, pp. 1398 - 1404,
    Journal articles | 2022
    Kariyawasam DST; D'Silva AM; Herbert K; Howells J; Carey K; Kandula T; Farrar MA; Lin C, 2022, 'Axonal excitability changes in children with spinal muscular atrophy treated with nusinersen', Journal of Physiology, 600, pp. 95 - 109,
    Journal articles | 2022
    Nguyen CQ; Kariyawasam D; Alba-Concepcion K; Grattan S; Hetherington K; Wakefield CE; Woolfenden S; Dale RC; Palmer EE; Farrar MA; Concepcion K, 2022, '鈥楢dvocacy groups are the connectors鈥: Experiences and contributions of rare disease patient organization leaders in advanced neurotherapeutics', Health Expectations, 25, pp. 3175 - 3191,
    Journal articles | 2021
    Kariyawasam D; D'silva A; Howells J; Herbert K; Geelan-Small P; Lin CSY; Farrar MA, 2021, 'Motor unit changes in children with symptomatic spinal muscular atrophy treated with nusinersen', Journal of Neurology Neurosurgery and Psychiatry, 92, pp. 78 - 85,
    Journal articles | 2021
    Kariyawasam DST; D'Silva AM; Vetsch J; Wakefield CE; Wiley V; Farrar MA, 2021, '鈥淲e needed this鈥: perspectives of parents and healthcare professionals involved in a pilot newborn screening program for spinal muscular atrophy', Eclinicalmedicine, 33, pp. 100742,
    Journal articles | 2021
    Kariyawasam DST; Farrar MA, 2021, 'Spinal muscular atrophy: A new treatment paradigm of proactive care', Medicine Today, 22, pp. 55 - 60
    Journal articles | 2020
    Kariyawasam D; Alexander IE; Kurian M; Farrar MA, 2020, 'Great expectations: Virus-mediated gene therapy in neurological disorders', Journal of Neurology Neurosurgery and Psychiatry, 91, pp. 849 - 860,
    Journal articles | 2020
    Kariyawasam DST; D鈥橲ilva A; Herbert K; Lin CSY; Geelan-Small P; Farrar MA, 2020, '7. Motor unit changes in children with spinal muscular atrophy treated with nusinersen', Clinical Neurophysiology, 131, pp. e3 - e4,
    Journal articles | 2020
    Kariyawasam DST; Russell JS; Wiley V; Alexander IE; Farrar MA, 2020, 'The implementation of newborn screening for spinal muscular atrophy: the Australian experience', Genetics in Medicine, 22, pp. 557 - 565,
    Journal articles | 2019
    Kariyawasam DST; D鈥檚ilva A; Lin C; Ryan MM; Farrar MA; D'Silva A, 2019, 'Biomarkers and the development of a personalized medicine approach in spinal muscular atrophy', Frontiers in Neurology, 10, pp. 898,
    Journal articles | 2018
    Anand G; Vasallo G; Spanou M; Thomas S; Pike M; Kariyawasam DS; Mehta S; Parry A; Durie-Gair J; Nicholson J; Lascelles K; Everett V; Gibbon FM; Jarvis N; Elston J; Evans DG; Halliday D, 2018, 'Diagnosis of sporadic neurofibromatosis type 2 in the paediatric population', Archives of Disease in Childhood, 103, pp. 463 - 469,
    Journal articles | 2018
    Kariyawasam D; Carey K; Jones K; Farrar MA, 2018, 'New and developing therapies in spinal muscular atrophy', Paediatric Respiratory Reviews, 28, pp. 3 - 10,
    Journal articles | 2018
    Sampaio H; Kariyawasam D; Buckley M; Mowat D; Robinson J; Taylor P; Jones K; Farrar M, 2018, 'Genetic carrier screening for Duchenne muscular dystrophy: the outcome of over forty years of genetic counselling on disease incidence in New South Wales Australia', NEUROMUSCULAR DISORDERS, 28, pp. S97 - S98,
    Journal articles | 2015
    Kariyawasam DS; McShane T, 2015, 'Brain tumours in paediatrics: When should they be suspected?', Archives of Disease in Childhood, 100, pp. 1102 - 1103,
  • Preprints | 2024
    Kariyawasam D; Scarfe J; Meagher C; Farrar M; Bhattacharya K; Carter S; Newson A; Otlowski M; Watson J; Millis N; Norris S, 2024, Genetic newborn screening stakeholder perspectives,
    Conference Papers | 2019
    Kariyawasam D; Sampaio H; Mowat D; Farrar MA, 2019, 'Genetic carrier screening for duchenne muscular dystrophy: the outcome of over twenty years of genetic counselling on disease epidemiology in a single-centre cohort study in new south wales (NSW), australia', Sydney Australia, presented at Australian and New Zealand Association of Neurologists, Sydney Australia
    Conference Abstracts | 2019
    Kariyawasam DS; Samapio H; Mowat D; Farrar M, 2019, 'GENETIC CARRIER SCREENING FOR DUCHENNE MUSCULAR DYSTROPHY: THE OUTCOME OF OVER TWENTY YEARS OF GENETIC COUNSELLING ON DISEASE EPIDEMIOLOGY IN A SINGLE-CENTRE COHORT STUDY IN NEW SOUTH WALES (NSW), AUSTRALIA', in JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, BMJ PUBLISHING GROUP, AUSTRALIA, Sydney, Vol. 90, presented at Annual Scientific Meeting of the Australian-and-New Zealand-Association-of-Neurologists (ANZAN), AUSTRALIA, Sydney, 21 May 2019 - 24 May 2019,
    Preprints |
    D'Silva AM; Sampaio H; Kariyawasam DST; Mowat D; Russell J; Junek Z; Jones KJ; Alexander IE; Best S; Wiley V; Farrar MA, Integrating a Pilot Newborn Screening for Spinal Muscular Atrophy Into the Australian Public Healthcare System,
    Preprints |
    Kariyawasam DST; D'Silva AM; Vetsch J; Wakefield C; Wiley V; Farrar MA, <i>'We Needed This'</i>: Perspectives of Parents and Healthcare Professionals Involved in a Pilot Newborn Screening Program for Spinal Muscular Atrophy,

  • 黑料网大事记 Paediatric Research Week Annual Prize (2019)

  • ANZCNS Best Research Award (2020)

  • Brain Foundation Grant (2021).

Publications

1.听Kariyawasam DST, Russell JS, Wiley V, Alexander IE, Farrar MA. The implementation of newborn screening for spinal muscular atrophy: the Australian experience.听Genet Med. 2020;22(3):557-565. doi:10.1038/s41436-019-0673-0

2. Kariyawasam DST, D'Silva A, Lin C, Ryan MM, Farrar MA. Biomarkers and the Development of a Personalized Medicine Approach in Spinal Muscular Atrophy.听Front Neurol. 2019;10:898. Published 2019 Aug 19. doi:10.3389/fneur.2019.00898

3.听Didu Kariyawasam, Kate A. Carey, Kristi J. Jones, Michelle A. Farrar. New and developing therapies in spinal muscular atrophy. Paediatric Respiratory Reviews. 2018. https://doi.org/10.1016/j.prrv.2018.03.003.

4.听Kariyawasam听D,听Alexander听IE,听Kurian听M, et al. Great expectations: virus-mediated gene therapy in neurological disorders. Journal of Neurology, Neurosurgery & Psychiatry听2020;91:849-860.

5.听D'Silva AM, Holland S, Kariyawasam D, et al. Onasemnogene abeparvovec in spinal muscular atrophy: an Australian experience of safety and efficacy.听Ann Clin Transl Neurol. 2022;9(3):339-350. doi:10.1002/acn3.51519

6.听D'Silva AM, Kariyawasam DST, Best S, Wiley V, Farrar MA; NSW SMA NBS Study Group. Integrating newborn screening for spinal muscular atrophy into health care systems: an Australian pilot programme.听Dev Med Child Neurol. 2022;64(5):625-632. doi:10.1111/dmcn.15117

7.听Kariyawasam D, D'Silva A, Howells J, et al. Motor unit changes in children with symptomatic spinal muscular atrophy treated with nusinersen [published online ahead of print, 2020 Oct 26].听J Neurol Neurosurg Psychiatry. 2020;92(1):78-85. doi:10.1136/jnnp-2020-324254

8.听Kariyawasam, D., D鈥橲ilva, A., Mowat, D.听et al.听Incidence of Duchenne muscular dystrophy in the modern era; an Australian study.听Eur J Hum Genet30, 1398鈥1404 (2022). https://doi.org/10.1038/s41431-022-01138-2

9. Kariyawasam DST, D'Silva AM, Vetsch J, Wakefield CE, Wiley V, Farrar MA. "We needed this": perspectives of parents and healthcare professionals involved in a pilot newborn screening program for spinal muscular atrophy.听EClinicalMedicine. 2021;33:100742. Published 2021 Feb 19. doi:10.1016/j.eclinm.2021.100742

10.听Kariyawasam DS, D'Silva AM, Sampaio H, et al. Newborn screening for spinal muscular atrophy in Australia: a non-randomised cohort study [published online ahead of print, 2023 Jan 17].听Lancet Child Adolesc Health. 2023;S2352-4642(22)00342-X. doi:10.1016/S2352-4642(22)00342-X

11.听Kariyawasam DST, D'Silva AM, Herbert K, et al. Axonal excitability changes in children with spinal muscular atrophy treated with nusinersen.听J Physiol. 2022;600(1):95-109. doi:10.1113/JP282249

12.听Nguyen CQ, Kariyawasam D, Alba-Concepcion K, et al. 'Advocacy groups are the connectors': Experiences and contributions of rare disease patient organization leaders in advanced neurotherapeutics.听Health Expect. 2022;25(6):3175-3191. doi:10.1111/hex.13625

13. D'Silva AM, Kariyawasam D, Venkat P, Mayoh C, Farrar MA. Identification of Novel CSF-Derived miRNAs in Treated Paediatric Onset Spinal Muscular Atrophy: An Exploratory Study.听Pharmaceutics. 2023;15(1):170. Published 2023 Jan 3. doi:10.3390/pharmaceutics15010170

14.听Farrar MA, Kariyawasam D, Grattan S, et al. Newborn Screening for the Diagnosis and Treatment of Duchenne Muscular Dystrophy.听J Neuromuscul Dis. 2023;10(1):15-28. doi:10.3233/JND-221535

15.听Kariyawasam DS, McShane T. Brain tumours in paediatrics: when should they be suspected?.听Arch Dis Child. 2015;100(12):1102-1103. doi:10.1136/archdischild-2015-308729

16.听Kariyawasam听DS,听Samapio听H,听Mowat听D, et al. Genetic carrier screening for duchenne muscular dystrophy: the outcome of over twenty years of genetic counselling on disease epidemiology in a single-centre cohort study in new south wales (NSW), Australia. Journal of Neurology, Neurosurgery & Psychiatry听2019;90:A8-A9.

17.听Anand听G,听Vasallo听G,听Spanou听M,..., Kariyawasam DS, et al. Diagnosis of sporadic neurofibromatosis type 2 in the paediatric population. Archives of Disease in Childhood听2018;103:463-469.

Society Memberships & Professional Activities:

  • Member of the Royal College of Paediatrics and Child Health, UK听
  • Royal Australasian College of Physicians听